000			02174 a2200529 4500
005			20250514163116.0
264		0	_c20041202
008			200412s 0 0 eng d
022			_a0888-8809
024	7		_a10.1210/me.2003-0196 _2doi
040			_aNLM _beng _cNLM
100	1		_aLeong, Hoyee
245	0	0	_aPotent ligand-independent estrogen receptor activation by 3,3'-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways. _h[electronic resource]
260			_bMolecular endocrinology (Baltimore, Md.) _cFeb 2004
300			_a291-302 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAnticarcinogenic Agents _xpharmacology
650	0	4	_aCyclic AMP Response Element-Binding Protein
650	0	4	_aCyclic AMP-Dependent Protein Kinases _xantagonists & inhibitors
650	0	4	_aCycloheximide _xpharmacology
650	0	4	_aEndometrial Neoplasms _xdrug therapy
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aEstradiol _xanalogs & derivatives
650	0	4	_aEstrogen Antagonists _xpharmacology
650	0	4	_aEstrogen Receptor alpha _xdrug effects
650	0	4	_aFemale
650	0	4	_aFlavonoids _xpharmacology
650	0	4	_aFulvestrant
650	0	4	_aHumans
650	0	4	_aIndoles _xpharmacology
650	0	4	_aIsoquinolines _xpharmacology
650	0	4	_aLigands
650	0	4	_aMAP Kinase Signaling System _xdrug effects
650	0	4	_aPhosphoprotein Phosphatases _xantagonists & inhibitors
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPoint Mutation
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aTranscription Factors _xdrug effects
650	0	4	_aTranscriptional Activation
650	0	4	_aTumor Cells, Cultured
700	1		_aRiby, Jacques E
700	1		_aFirestone, Gary L
700	1		_aBjeldanes, Leonard F
773	0		_tMolecular endocrinology (Baltimore, Md.) _gvol. 18 _gno. 2 _gp. 291-302
856	4	0	_uhttps://doi.org/10.1210/me.2003-0196 _zAvailable from publisher's website
999			_c14380116 _d14380116